Cargando…
Drug Resistance in Toxoplasma gondii
Toxoplasma gondii (T. gondii) is a global protozoan parasite infecting up to one-third of the world population. Pyrimethamine (PYR) and sulfadiazine (SDZ) are the most widely used drugs for treatment of toxoplasmosis; however, several failure cases have been recorded as well; suggesting the existenc...
Autores principales: | Montazeri, Mahbobeh, Mehrzadi, Saeed, Sharif, Mehdi, Sarvi, Shahabeddin, Tanzifi, Asal, Aghayan, Sargis A., Daryani, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215853/ https://www.ncbi.nlm.nih.gov/pubmed/30420849 http://dx.doi.org/10.3389/fmicb.2018.02587 |
Ejemplares similares
-
A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006–2016)
por: Montazeri, Mahbobeh, et al.
Publicado: (2017) -
Is there any association between Toxoplasma gondii infection and depression? A systematic review and meta-analysis
por: Nayeri Chegeni, Tooran, et al.
Publicado: (2019) -
Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease
por: Nayeri, Tooran, et al.
Publicado: (2021) -
Anti-Toxoplasma Activities of Zea Mays and Eryngium Caucasicum Extracts, In Vitro and In Vivo
por: Ahmadpour, Ehsan, et al.
Publicado: (2019) -
The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967–2017): a systematic review and meta-analysis
por: Montazeri, Mahbobeh, et al.
Publicado: (2020)